Berberine Reduces Atrial Lipotoxicity and Endoplasmic Reticulum Stress to Alleviate Heart Failure With Preserved Ejection Fraction ( HFpEF )‐Associated Atrial Fibrillation via AMPK Signaling
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70193 ↗At a glance
Journal article in Phytotherapy Research, 2026. Written by Zijun Cao and 12 co-authors. Institution: College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, People's Republic of China. Major MEDLINE topics: Berberine, Endoplasmic Reticulum Stress, AMP-Activated Protein Kinases, Atrial Fibrillation. Cited 1 times so far (Crossref); 88 references. Funded by: Liaoning Revitalization Talents Program, National Natural Science Foundation of China, Shenyang Science and Technology Project.
Topics: Herzinsuffizienz
Abstract (original language)
Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) frequently coexist due to shared risk factors, yet optimal therapeutic interventions remain elusive. Berberine (BBR), a widely used isoquinoline alkaloid, has demonstrated potential anti‐arrhythmic properties. However, its specific effects and regulatory mechanisms in HFpEF‐related AF are not fully understood. The present study was designed to clarify the pathological characteristics of HFpEF‐associated AF and further evaluate the therapeutic effects of BBR. In this study, we developed a high‐fat diet plus Nω‐Nitro‐L‐arginine methyl ester hydrochloride (L‐NAME)‐induced murine HFpEF model to investigate the impact of berberine on the pathogenesis of HFpEF‐associated AF. Bioinformatics and in vivo analyses revealed a progressive increase in atrial endoplasmic reticulum (ER) stress and lipid metabolic dysregulation. The HFpEF model exhibited significant atrial structural and electrical remodeling, which was dose‐dependently reversed by berberine treatment. Further investigation showed that berberine effectively preserved atrial lipid metabolism, reduced ER stress and atrial inflammation, and restored atrial AMP‐activated protein kinase (AMPK) activity. These protective effects were abolished by Compound C treatment, yet replicated by metformin or 4‐phenylbutyric acid administration. Notably, the beneficial effects of berberine were validated in an isoprenaline/palmitic acid (ISO/PA)‐treated HL‐1 cell model. Our study highlights the therapeutic potential of berberine in mitigating HFpEF‐associated atrial ER stress, lipid accumulation, and inflammatory responses. By targeting and preserving atrial AMPK signaling, berberine offers a promising therapeutic approach to combat HFpEF‐associated AF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, People's Republic of China.
- State Key Laboratory of Frigid Zone Cardiovascular Disease, Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning, People's Republic of China.
- Postgraduate College, China Medical University, Shenyang, Liaoning, People's Republic of China.
ORCID profiles: Jinfeng Duan, Liming Yu, Huishan Wang
Funding
- Liaoning Revitalization Talents Program
- National Natural Science Foundation of China
- Shenyang Science and Technology Project
- Natural Science Foundation of Liaoning Province
- Chinese PLA Northern Theater Command General Hospital
Cite
APA
Cao, Z., Duan, J., Meng, S., Zhou, Z., Huang, Y., Chen, X., Zhao, J., Huang, T., Zhang, G., Su, T., Yu, L., Yin, Z., & Wang, H. (2026). Berberine Reduces Atrial Lipotoxicity and Endoplasmic Reticulum Stress to Alleviate Heart Failure With Preserved Ejection Fraction ( HFpEF )‐Associated Atrial Fibrillation via AMPK Signaling. Phytotherapy Research. https://doi.org/10.1002/ptr.70193
Vancouver
Cao Z, Duan J, Meng S, Zhou Z, Huang Y, Chen X, et al. Berberine Reduces Atrial Lipotoxicity and Endoplasmic Reticulum Stress to Alleviate Heart Failure With Preserved Ejection Fraction ( HFpEF )‐Associated Atrial Fibrillation via AMPK Signaling. Phytotherapy Research. 2026. doi:10.1002/ptr.70193
BibTeX
@article{Cao2026,
author = {Cao, Zijun and Duan, Jinfeng and Meng, Shan and Zhou, Zijun and Huang, Yuting and Chen, Xin and Zhao, Jikai and Huang, Tao and Zhang, Guoxin and Su, Tong and Yu, Liming and Yin, Zongtao and Wang, Huishan},
title = {Berberine Reduces Atrial Lipotoxicity and Endoplasmic Reticulum Stress to Alleviate Heart Failure With Preserved Ejection Fraction ( HFpEF )‐Associated Atrial Fibrillation via AMPK Signaling},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70193}
}
EUVIMED